AIDS Related Primary CNS Lymphoma Market

AIDS related primary CNS lymphoma sales will strengthen through 2036, anchored by methotrexate at a 44.3% share as the leading drug type segment. The market value stood at USD 1.3 billion in 2025 and is forecast to reach USD 2.7 billion by 2036 across key growth regions including China and India.